Skip to main content

Can Tecfidera Cause Weight Gain?

Key Takeaways

  • Tecfidera (dimethyl fumarate) is a common treatment option for relapsing forms of multiple sclerosis, including relapsing-remitting MS (RRMS).
  • Weight gain is not listed among the most common side effects of Tecfidera in clinical trials or official FDA prescribing information.
  • Some people may notice weight changes indirectly due to gastrointestinal side effects, changes in physical activity, or other medical conditions.
  • Tecfidera can cause serious side effects, including lymphopenia (low level of lymphocytes), liver problems, allergic reactions, and rare brain infections such as progressive multifocal leukoencephalopathy (PML).
  • Patients taking Tecfidera should stay in regular contact with their healthcare provider, who may order blood tests to monitor lymphocytes and liver function.

Understanding Tecfidera for Multiple Sclerosis

Tecfidera is the brand name for dimethyl fumarate, an oral delayed-release medication approved by the Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis (MS). These include:

Shop Medications

,
  • Relapsing-remitting MS (RRMS)
  • Clinically isolated syndrome
  • Active secondary progressive disease

Multiple sclerosis affects the immune system, causing inflammation that damages nerve fibers in the brain and spinal cord. This damage can create lesions that interfere with communication between the brain and the body.

Tecfidera works by helping regulate immune activity and reducing inflammation. By doing so, it may lower the number of MS relapses and slow the progression of disability.

Because MS symptoms such as clumsiness, weakness, or balance problems can affect daily activity levels, many people are understandably concerned about medication side effects that might influence weight or metabolism.

Does Tecfidera Cause Weight Gain?

According to clinical trials and the official prescribing information, weight gain is not considered a common side effect of Tecfidera.

The most common side effects reported in studies include:

  • Flushing, which may cause redness or a burning sensation
  • Abdominal pain
  • Nausea
  • Diarrhea
  • Vomiting
  • Rash
  • Itching

These side effects tend to be more noticeable during the first month of treatment and may improve over time. Some patients take Tecfidera with food, including a high-fat meal, to reduce flushing or stomach discomfort.

Although weight gain itself is not typically associated with Tecfidera, a few indirect factors could contribute to changes in body weight.

Why Some People Taking Tecfidera Notice Weight Changes

While Tecfidera does not directly cause weight gain in most patients, weight changes can still occur for several reasons.

Changes in Activity From MS Symptoms

Multiple sclerosis can cause symptoms such as:

  • Fatigue
  • Muscle weakness
  • Balance problems
  • Coordination issues

These symptoms may reduce physical activity. Lower activity levels can sometimes lead to gradual weight gain over time.

Gastrointestinal Side Effects

Some patients experience gastrointestinal issues, including:

  • Nausea
  • Abdominal pain
  • Diarrhea

These symptoms may temporarily reduce appetite or affect eating patterns. When symptoms improve, normal eating habits may return, which can lead to weight fluctuations.

Other Medical Conditions

Weight changes can also be linked to:

  • Hormonal changes
  • Other medications used to manage multiple sclerosis
  • Lifestyle or dietary changes
  • Reduced mobility during MS flare-ups

A healthcare professional can help determine whether weight changes are related to medication or other health factors.

Important Tecfidera Side Effects to Know

Even though weight gain is not common, Tecfidera does have some potentially serious side effects that require monitoring.

Lymphopenia

Tecfidera can lower lymphocytes, a type of white blood cell involved in immune defense. Low levels, called lymphopenia, may increase the risk of infections.

Your healthcare provider will usually order blood tests to check cell counts before starting treatment and periodically afterward.

Progressive Multifocal Leukoencephalopathy (PML)

One rare but life-threatening complication linked to severe lymphopenia is progressive multifocal leukoencephalopathy (PML).

PML is a brain infection caused by a virus that usually remains dormant in the body. Symptoms may include:

  • Increasing weakness
  • Vision problems (blindness, double vision)
  • Confusion
  • Clumsiness/loss of coordination (ataxia)
  • Speech difficulties (aphasia)

Any new neurological symptoms should be reported to a healthcare provider immediately.

Liver Problems

Tecfidera may cause liver damage in rare cases. Warning signs include:

  • Dark urine
  • Yellowing of the skin or eyes
  • Persistent nausea
  • Severe fatigue
  • Severe abdominal pain (especially in the upper right part of the stomach)

Doctors typically monitor liver function through routine blood tests.

Serious Infections

Because Tecfidera affects the immune system, it may increase the risk of serious infections, including:

  • Herpes zoster
  • Viral infections
  • Other opportunistic infections

Patients should report fever, persistent illness, or unusual symptoms to their healthcare provider.

Allergic Reaction

In rare cases, Tecfidera may cause a severe allergic reaction. Symptoms may include:

  • Swelling of the face or throat
  • Difficulty breathing
  • Severe rash

Emergency medical attention should be sought if these symptoms occur.

Other Considerations When Taking Tecfidera

Before starting Tecfidera, patients should discuss their full medical history with their healthcare provider, including:

  • Existing medical conditions, including if you have low white blood cell counts or an infection
  • If you are pregnant or breastfeeding
  • Current medications for possible drug interactions

Your doctor may also review your liver function, immune status, and overall treatment plan to determine whether Tecfidera is the right treatment option.

Other MS medications, such as Copaxone, may sometimes be considered depending on a patient’s health history and disease progression.

Patients can also report suspected side effects to the FDA MedWatch program.

When to Talk to Your Healthcare Provider

If you are taking Tecfidera and notice unexpected weight gain, discuss it with your healthcare professional. They may evaluate:

  • Diet and activity level
  • Other medications
  • Hormonal or metabolic conditions
  • MS-related mobility changes

In most cases, weight changes can be managed through lifestyle changes or by addressing underlying factors.

FAQs

Is weight gain listed among Tecfidera side effects?

No. Weight gain is not listed among the most common side effects of Tecfidera in clinical trials or FDA prescribing information. However, some patients may still experience weight changes due to lifestyle factors, MS symptoms, or other medications.

What are the most common side effects of Tecfidera?

The most common side effects of Tecfidera include flushing and gastrointestinal symptoms like nausea, vomting, diarrhea, and abdominal pain. These effects are often most noticeable during the first month of treatment and may improve over time.

What is progressive multifocal leukoencephalopathy (PML) that can occur with Tecfidera?

Progressive multifocal leukoencephalopathy (PML) is a rare but life-threatening brain infection that can occur when the immune system is severely weakened. It has been reported in patients with prolonged lymphopenia while taking Tecfidera.

How are patients monitored while taking Tecfidera?

Doctors typically perform regular blood tests to monitor blood cell counts such as lymphocytes and liver function. Monitoring helps identify potential complications early and reduce the risk of infections or other serious side effects.

Can Tecfidera interact with other medications?

Yes. Drug interactions may occur depending on other medications a patient is taking. It is important to inform your healthcare provider about all prescriptions, supplements, and over-the-counter medications.

Sources